MA41168A - Nouveaux composés antibactériens - Google Patents
Nouveaux composés antibactériensInfo
- Publication number
- MA41168A MA41168A MA041168A MA41168A MA41168A MA 41168 A MA41168 A MA 41168A MA 041168 A MA041168 A MA 041168A MA 41168 A MA41168 A MA 41168A MA 41168 A MA41168 A MA 41168A
- Authority
- MA
- Morocco
- Prior art keywords
- antibacterial compounds
- new antibacterial
- new
- compounds
- antibacterial
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14198412 | 2014-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41168A true MA41168A (fr) | 2017-10-24 |
Family
ID=52347083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041168A MA41168A (fr) | 2014-12-17 | 2015-12-10 | Nouveaux composés antibactériens |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10369130B2 (fr) |
| EP (1) | EP3233826A1 (fr) |
| JP (1) | JP2017537938A (fr) |
| AR (1) | AR103028A1 (fr) |
| MA (1) | MA41168A (fr) |
| WO (1) | WO2016096631A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| EP3468975B1 (fr) | 2016-06-08 | 2020-04-01 | Aziende Chimiche Riunite Angelini Francesco A.C.R. | Nouveaux composés antibactériens |
| CA3162979A1 (fr) * | 2019-12-23 | 2021-07-01 | Upender Velaparthi | Derives piperazine substitues utiles en tant qu'activateurs de lymphocytes t |
| IL294148A (en) | 2019-12-23 | 2022-08-01 | Bristol Myers Squibb Co | Substituted quinazolinyl compounds are useful as t-cell activators |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2637591B1 (fr) * | 1988-10-11 | 1992-10-23 | Synthelabo | Derives de quinoleinone, leur preparation et leur application en therapeutique |
| FR2655988B1 (fr) | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| IL105716A0 (en) * | 1992-06-08 | 1993-09-22 | Richter Gedeon Vegyeszet | Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them |
| HU215397B (hu) * | 1994-08-29 | 1998-12-28 | Richter Gedeon Vegyészeti Gyár Rt. | (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására |
| AU6972096A (en) | 1996-09-09 | 1998-03-26 | Aironet Wireless Communications, Inc. | Cellular communication system with dynamically modified data transmission parameters |
| FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
| DE19900544A1 (de) | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
| FR2822154B1 (fr) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| WO2003106452A2 (fr) * | 2002-06-12 | 2003-12-24 | Millennium Pharmaceuticals, Inc. | Antagonistes du recepteur de l'hormone de melano-concentration |
| TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
| CA2557541C (fr) * | 2004-02-26 | 2014-12-16 | Aska Pharmaceutical Co., Ltd. | Derives de pyrimidine |
| CA2568835C (fr) * | 2004-06-30 | 2014-05-27 | Janssen Pharmaceutica N.V. | Derives de quinazolinone en tant qu'inhibiteurs de parp |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| JP5314244B2 (ja) * | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
| NZ555491A (en) * | 2005-01-03 | 2010-01-29 | Univ Siena | Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| JP2008528604A (ja) * | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
| MX2007010076A (es) * | 2005-02-17 | 2007-10-16 | Astellas Pharma Inc | Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo. |
| WO2006090272A1 (fr) * | 2005-02-22 | 2006-08-31 | Warner-Lambert Company Llc | Isoquinoline [1,8]naphthyridin-2-ones et composes relatifs destines au traitement de la schizophrenie |
| JP2009507791A (ja) * | 2005-08-29 | 2009-02-26 | メルク エンド カムパニー インコーポレーテッド | ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法 |
| EP1954287B2 (fr) * | 2005-10-31 | 2016-02-24 | Merck Sharp & Dohme Corp. | Inhibiteurs de la cetp |
| EP1903037A1 (fr) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | Dérivés de 1-[(hétéro)aryl]-3-[hétéroaryl-pipéridine-4-yl]thiourée en tant que modulateurs de récepteurs EP2 |
| EP1903038A1 (fr) | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | Dérivés N-(1-hetaryl-piperidine-4-yl)-(het)arylamide utilisées comme modulateurs du recepteur EP2 |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| DE602007007906D1 (de) | 2007-05-11 | 2010-09-02 | Coatex Sas | Use of a reverse emulsion of an acrylamide polymer with an acrylic monomer as a stabilising agent and foam reducer, in a method for the grinding of mineral materials and binders in an aqueous medium. |
| US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
| US8716280B2 (en) | 2009-01-21 | 2014-05-06 | Basilea Pharmaceutica Ag | Bicyclic antibiotics |
| WO2011057110A1 (fr) | 2009-11-06 | 2011-05-12 | Ruprecht-Karls-Universitat-Heidelberg | Agonistes de gpr109a pour le traitement de l'ischémie cérébrale |
| US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
| IN2014CN04126A (fr) | 2011-11-08 | 2015-07-10 | Actelion Pharmaceuticals Ltd | |
| TW201326180A (zh) | 2011-11-30 | 2013-07-01 | Actelion Pharmaceuticals Ltd | ３，７－二取代八氫－２Ｈ－吡啶并［４，３－ｅ］［１，３］□嗪－２－酮抗生素 |
| JP2016500084A (ja) | 2012-11-26 | 2016-01-07 | リアオニン エミー バイオロジカル ファーマシューティカル カンパニー リミテッドＬｉａｏｎｉｎｇ Ｅｍｍｙ Ｂｉｏｌｏｇｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．，Ｌｔｄ | 含窒素ベンゾ複素五員環基ピペリジン又はピペラジン誘導体及びその作製方法並びに薬剤組成物 |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
-
2015
- 2015-12-10 MA MA041168A patent/MA41168A/fr unknown
- 2015-12-11 WO PCT/EP2015/079352 patent/WO2016096631A1/fr not_active Ceased
- 2015-12-11 JP JP2017531401A patent/JP2017537938A/ja not_active Ceased
- 2015-12-11 EP EP15808202.4A patent/EP3233826A1/fr not_active Withdrawn
- 2015-12-11 US US15/534,874 patent/US10369130B2/en not_active Expired - Fee Related
- 2015-12-15 AR ARP150104085A patent/AR103028A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20170368017A1 (en) | 2017-12-28 |
| AR103028A1 (es) | 2017-04-12 |
| WO2016096631A1 (fr) | 2016-06-23 |
| EP3233826A1 (fr) | 2017-10-25 |
| US10369130B2 (en) | 2019-08-06 |
| JP2017537938A (ja) | 2017-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44050A (fr) | Nouveaux composés | |
| MA42293A (fr) | Composés antibactériens | |
| MA44233A (fr) | Nouveaux composés | |
| ME03419B (fr) | Composés dihydroisoquinolinone substitués | |
| LT3197883T (lt) | Nauji junginiai | |
| LT3134402T (lt) | 4-amino-imidazochinolino junginiai | |
| EP3334584A4 (fr) | Extrudeuse | |
| PT3298027T (pt) | Compostos depsipéptidos antelmínticos | |
| MA45221A (fr) | Nouveaux composés antibactériens | |
| DK3157926T3 (da) | Organiske forbindelser | |
| EP3464336A4 (fr) | Composés | |
| EP3288600C0 (fr) | Nanofibres antibactériennes | |
| BR112016030730A2 (pt) | Composto | |
| LT3362444T (lt) | Junginiai | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| BR112017014839A2 (pt) | novos microbicidas | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| DK3347403T3 (da) | Polyalkoxyfedtforbindelse | |
| ME03312B (fr) | Pyroglutamate de vortioxetine | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| BR112016018442A2 (pt) | agentes antibacterianos | |
| MA49522A (fr) | Nouveaux composés de quinoléinone | |
| EP3259254A4 (fr) | Composés thérapeutiques | |
| HUE039805T2 (hu) | Új szulfonilaminobenzamid vegyületek | |
| LT3331885T (lt) | Junginiai |